PMV PHARMACEUTICALS, INC. Depreciation
PMV PHARMACEUTICALS, INC. (PMVP) reported Depreciation of $24.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-06-30 was $24.00K, a 25.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-03-31 was $34.00K, a 8.11% decline year-over-year.
- PMV PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-12-31 was $33.00K, a 15.38% decline year-over-year.
- PMV PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-09-30 was $32.00K, a 91.37% decline year-over-year.
- PMV PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $133.00K, a 88.37% decline from fiscal 2024.
- PMV PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $1.14M, a 8.99% decline from fiscal 2023.
- PMV PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $1.26M, a 299.05% increase from fiscal 2022.
- PMV PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $315.00K, a 2.61% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-14 | $58.00K 10-Q · filed 2026-08-14 | $91.00K derived: sum of 3 quarters · filed 2026-08-14 | $123.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-12 | $67.00K derived: sum of 2 quarters · filed 2026-05-12 | $99.00K derived: sum of 3 quarters · filed 2026-05-12 | $131.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $65.00K derived: sum of 2 quarters · filed 2026-03-06 | $97.00K derived: sum of 3 quarters · filed 2026-08-14 | $133.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $32.00K 10-Q · filed 2025-11-12 | $64.00K derived: sum of 2 quarters · filed 2026-08-14 | $100.00K 10-Q · filed 2025-11-12 | $140.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $32.00K 10-Q · filed 2026-08-14 | $69.00K 10-Q · filed 2026-08-14 | $108.00K derived: sum of 3 quarters · filed 2026-08-14 | $479.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $37.00K 10-Q · filed 2026-05-12 | $76.00K derived: sum of 2 quarters · filed 2026-05-12 | $447.00K derived: sum of 3 quarters · filed 2026-05-12 | $819.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $410.00K derived: sum of 2 quarters · filed 2026-03-06 | $782.00K derived: sum of 3 quarters · filed 2026-03-06 | $1.14M 10-K · filed 2026-03-06 |
| 2024-09-30 | $371.00K 10-Q · filed 2025-11-12 | $743.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.10M 10-Q · filed 2025-11-12 | $1.46M derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-06-30 | $372.00K 10-Q · filed 2025-08-07 | $734.00K 10-Q · filed 2025-08-07 | $1.09M derived: sum of 3 quarters · filed 2026-03-06 | $1.45M derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-03-31 | $362.00K 10-Q · filed 2025-05-09 | $721.00K derived: sum of 2 quarters · filed 2026-03-06 | $1.08M derived: sum of 3 quarters · filed 2026-03-06 | $1.45M derived: sum of 4 quarters · filed 2026-03-06 |
| 2023-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $717.00K derived: sum of 2 quarters · filed 2026-03-06 | $1.09M derived: sum of 3 quarters · filed 2026-03-06 | $1.26M 10-K · filed 2026-03-06 |
| 2023-09-30 | $358.00K 10-Q · filed 2024-11-07 | $727.00K derived: sum of 2 quarters · filed 2024-11-07 | $898.00K 10-Q · filed 2024-11-07 | $973.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $369.00K 10-Q · filed 2024-08-08 | $540.00K 10-Q · filed 2024-08-08 | $615.00K derived: sum of 3 quarters · filed 2025-03-03 | $689.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $171.00K 10-Q · filed 2024-05-09 | $246.00K derived: sum of 2 quarters · filed 2025-03-03 | $320.00K derived: sum of 3 quarters · filed 2025-03-03 | $402.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $149.00K derived: sum of 2 quarters · filed 2025-03-03 | $231.00K derived: sum of 3 quarters · filed 2025-03-03 | $315.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $74.00K 10-Q · filed 2023-11-09 | $156.00K derived: sum of 2 quarters · filed 2023-11-09 | $240.00K 10-Q · filed 2023-11-09 | $317.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $82.00K 10-Q · filed 2023-08-09 | $166.00K 10-Q · filed 2023-08-09 | $243.00K derived: sum of 3 quarters · filed 2024-02-29 | $323.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $84.00K 10-Q · filed 2023-05-10 | $161.00K derived: sum of 2 quarters · filed 2024-02-29 | $241.00K derived: sum of 3 quarters · filed 2024-02-29 | $312.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $157.00K derived: sum of 2 quarters · filed 2024-02-29 | $228.00K derived: sum of 3 quarters · filed 2024-02-29 | $307.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $80.00K 10-Q · filed 2022-11-08 | $151.00K derived: sum of 2 quarters · filed 2022-11-08 | $230.00K 10-Q · filed 2022-11-08 | $291.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $71.00K 10-Q · filed 2022-08-09 | $150.00K 10-Q · filed 2022-08-09 | $211.00K derived: sum of 3 quarters · filed 2023-03-01 | $286.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $79.00K 10-Q · filed 2022-05-10 | $140.00K derived: sum of 2 quarters · filed 2023-03-01 | $215.00K derived: sum of 3 quarters · filed 2023-03-01 | $302.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $136.00K derived: sum of 2 quarters · filed 2023-03-01 | $223.00K derived: sum of 3 quarters · filed 2023-03-01 | $318.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $75.00K 10-Q · filed 2021-11-12 | $162.00K derived: sum of 2 quarters · filed 2021-11-12 | $257.00K 10-Q · filed 2021-11-12 | $351.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $87.00K 10-Q · filed 2021-08-13 | $182.00K 10-Q · filed 2021-08-13 | $276.00K derived: sum of 3 quarters · filed 2022-03-01 | $382.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $94.00K 10-Q · filed 2021-05-14 | $189.00K derived: sum of 2 quarters · filed 2022-03-01 | $295.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $201.00K derived: sum of 2 quarters · filed 2022-03-01 | $388.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $106.00K 10-Q · filed 2020-11-13 | $293.00K 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $338.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |